Junzhen Wu

1.6k total citations
41 papers, 1.3k citations indexed

About

Junzhen Wu is a scholar working on Physiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Junzhen Wu has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Infectious Diseases and 8 papers in Pharmacology. Recurrent topics in Junzhen Wu's work include Antimicrobial Resistance in Staphylococcus (7 papers), Pain Mechanisms and Treatments (6 papers) and Nerve injury and regeneration (6 papers). Junzhen Wu is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Pain Mechanisms and Treatments (6 papers) and Nerve injury and regeneration (6 papers). Junzhen Wu collaborates with scholars based in China, Australia and United States. Junzhen Wu's co-authors include Shijin Xia, Bill Kalionis, Wenbin Wan, Xiantao Tai, Songbai Zheng, Ramin Khanabdali, Tao Sun, Shaofeng Pu, Dongping Du and Yongming Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Neuroscience.

In The Last Decade

Junzhen Wu

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junzhen Wu China 16 368 284 193 137 108 41 1.3k
Meng Sun China 19 565 1.5× 126 0.4× 260 1.3× 127 0.9× 153 1.4× 49 1.3k
Giovanna Casili Italy 25 666 1.8× 262 0.9× 197 1.0× 102 0.7× 126 1.2× 92 1.6k
Xiaohong Chen China 23 545 1.5× 259 0.9× 149 0.8× 107 0.8× 61 0.6× 79 1.5k
Raffaele Simeoli Italy 20 482 1.3× 396 1.4× 99 0.5× 239 1.7× 107 1.0× 39 1.4k
Chunqiu Chen China 22 483 1.3× 165 0.6× 158 0.8× 129 0.9× 123 1.1× 61 1.5k
Nima Sanadgol Iran 25 636 1.7× 233 0.8× 162 0.8× 193 1.4× 115 1.1× 82 1.6k
Éric Rousseau Canada 29 798 2.2× 490 1.7× 143 0.7× 179 1.3× 69 0.6× 90 2.1k
Aldo Pinto Italy 22 381 1.0× 272 1.0× 160 0.8× 70 0.5× 59 0.5× 50 1.4k
Antonio Damato Italy 21 368 1.0× 241 0.8× 223 1.2× 144 1.1× 51 0.5× 40 1.3k
Feng‐Ming Ho Taiwan 25 699 1.9× 214 0.8× 262 1.4× 134 1.0× 139 1.3× 39 1.8k

Countries citing papers authored by Junzhen Wu

Since Specialization
Citations

This map shows the geographic impact of Junzhen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junzhen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junzhen Wu more than expected).

Fields of papers citing papers by Junzhen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junzhen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junzhen Wu. The network helps show where Junzhen Wu may publish in the future.

Co-authorship network of co-authors of Junzhen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Junzhen Wu. A scholar is included among the top collaborators of Junzhen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junzhen Wu. Junzhen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Junzhen, Qiong Wei, Yi Jin, et al.. (2024). Safety, tolerability, and pharmacokinetics of a novel anti-influenza agent ZX-7101A tablets in healthy chinese participants: A first-in-human phase I clinical study. International Journal of Antimicrobial Agents. 65(1). 107381–107381. 2 indexed citations
3.
Xu, Yongming, Junzhen Wu, Qingqing Jiang, et al.. (2023). Prediction of the Efficacy of Lumbar Sympathetic Block in Patients with Lower Extremity Complex Regional Pain Syndrome Type 1 Based on the Sympathetic Skin Response. Pain and Therapy. 12(3). 785–796. 3 indexed citations
4.
Wu, Junzhen, Xinyi Yang, Jufang Wu, et al.. (2023). Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis. Frontiers in Pharmacology. 14. 1135007–1135007. 5 indexed citations
5.
Pu, Shaofeng, Yi‐Yang Wu, Qingjian Han, et al.. (2022). Ultrasound-Guided Extraforaminal Thoracic Nerve Root Block Through the Midpoint of the Inferior Articular Process and the Parietal Pleura: A Clinical Application of Thoracic Paravertebral Nerve Block. SHILAP Revista de lepidopterología. 6 indexed citations
6.
Pu, Shaofeng, et al.. (2022). Real-time ultrasound-guided stellate ganglion block for migraine: an observational study. BMC Anesthesiology. 22(1). 78–78. 8 indexed citations
7.
Xu, Yongming, Qingqing Jiang, Shaofeng Pu, et al.. (2022). The Tourniquet Ischemia Test Effectively Predicts the Efficacy of Lumbar Sympathetic Block in Patients with Lower Extremity Complex Regional Pain Syndrome Type 1. Journal of Pain Research. Volume 15. 1659–1667. 2 indexed citations
9.
Cheng, Dong‐Sheng, et al.. (2022). The Effects of Fluid Hydration Status on Ultrasound Muscle Measurement in Hemodialysis Patients. Journal of Renal Nutrition. 33(1). 214–218. 4 indexed citations
10.
Pu, Shaofeng, Junzhen Wu, Qingjian Han, et al.. (2020). <p>Ultrasonography-Guided Radiofrequency Ablation for Painful Stump Neuromas to Relieve Postamputation Pain: A Pilot Study</p>. Journal of Pain Research. Volume 13. 3437–3445. 10 indexed citations
11.
Li, Li, Hailan Wu, Yuancheng Chen, et al.. (2020). Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients. Clinical Therapeutics. 42(5). 818–829. 19 indexed citations
12.
Xu, Yongming, et al.. (2020). Tamoxifen attenuates reactive astrocyte-induced brain metastasis and drug resistance through the IL-6/STAT3 signaling pathway. Acta Biochimica et Biophysica Sinica. 52(12). 1299–1305. 14 indexed citations
13.
Wu, Junzhen, Kun Wang, Yuancheng Chen, et al.. (2019). Concentration–response modeling of ECG data from early-phase clinical studies to assess QT prolongation risk of contezolid (MRX-I), an oxazolidinone antibacterial agent. Journal of Pharmacokinetics and Pharmacodynamics. 46(6). 531–541. 9 indexed citations
15.
Xia, Shijin, Songbai Zheng, Ramin Khanabdali, et al.. (2016). An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment. Journal of Immunology Research. 2016. 1–12. 406 indexed citations
16.
Xu, Yongming, Yanrong Zhu, Xin Zhang, et al.. (2016). Anti-nociceptive roles of the glia-specific metabolic inhibitor fluorocitrate in paclitaxel-evoked neuropathic pain. Acta Biochimica et Biophysica Sinica. 48(10). 902–908. 21 indexed citations
17.
Xu, Yongming, Xin Zhang, Shaofeng Pu, et al.. (2014). Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions. Acta Biochimica et Biophysica Sinica. 46(11). 942–949. 27 indexed citations
18.
Pu, Shaofeng, Yongming Xu, Dongping Du, et al.. (2012). Minocycline attenuates mechanical allodynia and expression of spinal NMDA receptor 1 subunit in rat neuropathic pain model. Journal of Physiology and Biochemistry. 69(3). 349–357. 17 indexed citations
19.
Zhang, Xiaoxin, Jilong Wang, Quanhong Zhou, et al.. (2011). Brain-derived neurotrophic factor–activated astrocytes produce mechanical allodynia in neuropathic pain. Neuroscience. 199. 452–460. 35 indexed citations
20.
Ogle, Cora K., et al.. (1994). Heterogeneity of kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, AND IL-6. Inflammation. 18(5). 511–523. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026